The E2F family of transcription factors are essential for the regulati
on of genes required for appropriate progression through the cell cycl
e. Five members of the E2F family have been previously reported, namel
y E2F1-5. All five are key elements in transcriptional regulation of e
ssential genes, and they can be divided into two functional groups, th
ose that induce S-phase progression when overexpressed in quiescent ce
lls (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe th
e identification of a novel member of this family, which we refer to a
s E2F-6, E2F-6 shares significant homology with E2Fs 1-5, especially w
ithin the DNA binding, heterodimerization and marked box domains. Unli
ke E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein bindin
g domain, hence, forms a unique third group within the E2F family, E2F
-6 is a nuclear protein that can form heterodimers with the DP protein
s (both DP-I and DP-2) in vitro and in vivo. Our results show that the
complex formed between E2F-6 and the DP proteins, possesses high DNA
binding activity, displaying a preference for a TTTCCCGC E2F recogniti
on site, which is slightly different to the E2F consensus site derived
from the E2 promoter (TTTCGCGC). In contrast to the other members of
the E2F family, ectopic expression of E2F-6 inhibits transcription fro
m promoters possessing E2F recognition sites rather than activating tr
anscription. In addition, overexpression of E2F-6 suppresses the trans
activational effects of coexpression of E2F-1 and DP-1. The inhibitory
effect of E2F-6 is dependent on its DIVA binding activity and its abi
lity to form heterodimers with the DPs, Interestingly, ectopic express
ion of E2F-6 leads to accumulation of cells in S-phase, Our data sugge
st that E2F-6 expression delays the exit from S-phase rather than indu
cing S-phase, which further emphasizes the functional difference betwe
en E2F-6 and the previously known E2F family members.